| Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes DE Leisman, L Ronner, R Pinotti, MD Taylor, P Sinha, CS Calfee, ... The Lancet Respiratory Medicine 8 (12), 1233-1244, 2020 | 921 | 2020 |
| CTLA-4 blockade synergizes therapeutically with PARP inhibition in BRCA1-deficient ovarian cancer T Higuchi, DB Flies, NA Marjon, G Mantia-Smaldone, L Ronner, ... Cancer immunology research 3 (11), 1257-1268, 2015 | 299 | 2015 |
| Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis L Ronner, N Podoltsev, J Gotlib, ML Heaney, AT Kuykendall, C O’Connell, ... Blood, The Journal of the American Society of Hematology 135 (19), 1696-1703, 2020 | 75 | 2020 |
| Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes. Lancet Respir Med. 2020; 8 (12 … DE Leisman, L Ronner, R Pinotti, MD Taylor, P Sinha, CS Calfee, ... DOI: https://doi. org/10.1016/S2213-2600 (20), 30404-5, 2020 | 58 | 2020 |
| Ctla-4 blockade synergizes therapeutically with parp inhibition in brca1-deficient ovarian cancer. Cancer Immunol. Res. 2015; 3: 1257–1268. doi: 10.1158/2326-6066 T Higuchi, DB Flies, NA Marjon, G Mantia-Smaldone, L Ronner, ... CIR-15-0044.[Europe PMC free article][Abstract][CrossRef][Academic Search], 2021 | 37 | 2021 |
| CTLA-4 blockade synergizes therapeutically with PARP inhibition in BRCA1-deficient ovarian cancer. Cancer Immunol Res. 2015; 3 (11): 1257–68 T Higuchi, DB Flies, NA Marjon, G Mantia-Smaldone, L Ronner, ... CIR-15-0044, 0 | 23 | |
| The immunomodulatory effects of pegylated liposomal doxorubicin are amplified in BRCA1− deficient ovarian tumors and can be exploited to improve treatment response in a mouse model G Mantia-Smaldone, L Ronner, A Blair, V Gamerman, C Morse, S Orsulic, ... Gynecologic Oncology 133 (3), 584-590, 2014 | 18 | 2014 |
| European LeukemiaNet response predicts disease progression but not thrombosis in polycythemia vera D Tremblay, A Srisuwananukorn, L Ronner, N Podoltsev, J Gotlib, ... Hemasphere 6 (6), e721, 2022 | 15 | 2022 |
| Online forums and the “step 1 climate”: perspectives from a medical student reddit user L Ronner, L Linkowski Academic Medicine 95 (9), 1329-1331, 2020 | 15 | 2020 |
| Response to meta-analysis of leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera L Ronner, J Mascarenhas, EL Moshier Blood Advances 3 (20), 3010-3012, 2019 | 13 | 2019 |
| US medical trainees’ knowledge of human papilloma virus and head and neck cancer BM Laitman, L Ronner, K Oliver, E Genden Otolaryngology–Head and Neck Surgery 162 (1), 56-59, 2020 | 11 | 2020 |
| Vaccine strategies for the treatment of lymphoma: preclinical progress and clinical trial update TU Marron, L Ronner, PE Martin, CR Flowers, JD Brody Immunotherapy 8 (11), 1335-1346, 2016 | 10 | 2016 |
| European LeukemiaNet (ELN) response predicts disease progression but not thrombosis or death in polycythemia vera (PV): An analysis of a multicenter database D Tremblay, A Srisuwananukorn, L Ronner, N Podoltsev, J Gotlib, ... Blood 138, 240, 2021 | 8 | 2021 |
| Improving the investigative approach to polycythaemia vera: a critical assessment of current evidence and vision for the future L Ronner, S Venugopal, E Moshier, J Mascarenhas The Lancet Haematology 8 (8), e605-e612, 2021 | 7 | 2021 |
| Ruxolitinib discontinuation in polycythemia vera: Patient characteristics, outcomes, and salvage strategies from a large multi-institutional database D Tremblay, L Ronner, N Podoltsev, J Gotlib, M Heaney, A Kuykendall, ... Leukemia Research 109, 106629, 2021 | 4 | 2021 |
| Assessing the importance of interleukin-6 in COVID-19–Authors' reply DE Leisman, L Ronner, R Pinotti, MD Taylor, P Sinha, CS Calfee, ... The Lancet Respiratory Medicine 9 (2), e14-e15, 2021 | 4 | 2021 |
| The role of otolaryngologists in eradicating human papillomavirus BM Laitman, L Ronner, E Genden JAMA Otolaryngology–Head & Neck Surgery 144 (12), 1186-1186, 2018 | 3 | 2018 |
| Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis: an analysis from a 520-patient retrospective multi-center database L Ronner, NA Podoltsev, J Gotlib, ML Heaney, AT Kuykendall, ... Blood 134, 2949, 2019 | 2 | 2019 |
| Resolution of acquired palmoplantar keratoderma and scurvy after treatment of multivitamin deficiencies CT Berry, KG Berry, J Abbott, AJ Jiang, L Ronner, NK Mollanazar, ... JAAD Case Reports 22, 27-30, 2022 | 1 | 2022 |
| Novel Machine Learning Algorithm Predicts Disease Progression in Polycythemia Vera (PV) with Readily-Available Baseline Characteristics A Srisuwananukorn, B Percha, G Abu-Zeinah, J Scandura, S Krichevsky, ... Blood 138, 2583, 2021 | 1 | 2021 |
